EMR Chemotoxicity Risk Calculator To Decrease Chemotherapy Toxicity

Completed · Not applicable

Conditions studied: Oncology, Chemotherapeutic Toxicity, Metastatic Solid Tumor

In brief

This study will formally test the quality improvement intervention of an EMR based tool that informs medical oncologists visiting a patient for the first time of potential risk of chemotherapy toxicity.

Key facts

Study ID

NCT05809557

Run by

Masonic Cancer Center, University of Minnesota

People needed

34

Starts

2023-01-09

Expected to finish

2024-01-09

Last updated by the study team

2024-02-28

Who can join

Age: 65 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• New outpatient visits with a medical oncologist following a new diagnosis of cancer and no prior history of chemotherapy treatment.
• aged > 65 will be included.

You may not qualify if…

• Patients who opt out of clinical research will be excluded from analysis, but not the intervention (which will be applied to all patients). Specifically, as sometimes opt-in/opt out status is coded ambiguously in the data we will only analyze results of patients with clear opt in and no history of opt out.
• Patients with no EHR data after initial oncologist appointment.

Where it is running

• Masonic Cancer Center, University of Minnesota — Minneapolis, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.